Show Parent

e-learning resources

Masterclass in airways disease

Target audience

Clinicians, trainees, scientists, pulmonologists, research fellows

Educational aims

Following this course, participants will be able to:

Have greater knowledge of the pharmacological and non-pharmacological treatment
Understand the investigation and management of the two diseases
Work in teams in the follow-up of the disease
Improve their communication skills
Engage in the research field

Download all media

Download all media

Latest updates in the guidelines of asthma Guy Brusselle (Belgium)
Latest updates in the guidelines of COPD Alberto Papi (Italy)
Assessing & monitoring airway diseases using lung function IIñigo Ojanguren Arranz (Spain)
Assessing & monitoring airway diseases using biomarkers Stylianos Loukides (Greece)
Assessing & monitoring airway diseases using imaging Sujal Desai (United Kingdom)
Do airway diseases start in the early life? Navarro Alvar Agusti Garcia (Spain)
Making clinical sense of phenotypes and endotypes of asthma Louis Renaud (Belgium)
Making clinical sense of phenotypes and endotypes of COPD Daiana Stolz (Switzerland)
Pharmacological treatment & current controversies in asthma Guy Brusselle (Belgium)
Pharmacological treatment & current controversies in COPD Mario Cazzola (Italy)
Non-pharmacological treatment in asthma and COPD Andre Nybeg (Sweden)
Can bronchiectasis be a negative prognostic factor for airway diseases? Montserrat Vendrell (Spain)
Severe asthma Antonio Spanevello (Italy)
Alfa 1 antitrypsin deficit: only COPD or asthma as well? Mario Cazzola (Italy)

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.